OneWorldHerald.com

FDA has Approved a New Drug for Dogs to Reduce Separation Anxiety

Image for representational purposes only

Food and Drug Administration (FDA), the federal agency of the United States Department of Health and Human Services has announced on Wednesday that clomipramine hydrochloride drug can be used by the dog owners to keep the anxious dogs calm and separated from anxiety. Clomipramine hydrochloride drug is generic for the brand name drug Clomicalm. According to the FDA, this drug is for dogs aged six months and has underlying anxiety about being left alone.

The FDA has considered this drug as a part of the behavioral training of the dogs. The dogs which spend most of the time along in a home, face separation anxiety and it is one of the most common behavioral problems in dogs.

According to the American Veterinary Medical Association, it can be diagnosed in up to 40 percent of dogs referred to behavioral practices in North America. Being separated is normal in young puppies and they require special attention at that time including good dog clothes, healthy food, and daily walk.

In some older dogs, separation anxiety can become problematic. The symptoms may include inappropriate urination and defecation, vocalization and destructiveness. The newly approved drug is helpful to reduce the separation anxiety in dogs.

The FDA has already approved another drug called Reconcile for the dogs which is also used to treat separation anxiety in dogs. Reconcile is an active ingredient of fluoxetine hydrochloride and the same ingredient is in the antidepressant drug Prozac.

Related News

Medical Prescriptions are now Needed to buy Herbal Supplement, Kratom

Alex Pritchard

Dr. Martin Schwarz Launches Bioscaling Gel as a Revolutionary Step in the Dental Industry

Joyce Burns

Scientists Recommend These 7 Ways to Increase your Daily Water Intake Capacity

Alex Pritchard

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More